Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.
about
Molecular Assays in Cytopathology for Thyroid CancerQPRT: a potential marker for follicular thyroid carcinoma including minimal invasive variant; a gene expression, RNA and immunohistochemical study.Thyroid cancer: current molecular perspectives.Molecular diagnostics of fine needle aspiration for the presurgical screening of thyroid nodules.Occult thyroid carcinomaEvaluation of a thyroid nodule.Tumorigenesis of papillary thyroid cancer is not BRAF-dependent in patients with acromegaly.Preoperative RAS mutational analysis is of great value in predicting follicular variant of papillary thyroid carcinomaIs follow-up BRAF(V600E) mutation analysis helpful in the differential diagnosis of thyroid nodules with negative results on initial analysis?Automated universal BRAF state detection within the activation segment in skin metastases by pyrosequencing-based assay U-BRAF(V600)The Frequency and Clinical Implications of the BRAF(V600E) Mutation in Papillary Thyroid Cancer Patients in Korea Over the Past Two Decades.TSH signaling overcomes B-RafV600E-induced senescence in papillary thyroid carcinogenesis through regulation of DUSP6.Subclassification of the "grey zone" of thyroid cytology; a retrospective descriptive study with clinical, cytological, and histological correlation.The utility of BRAF testing in the management of papillary thyroid cancer.Novel and Practical Scoring Systems for the Diagnosis of Thyroid Nodules25-Hydroxyvitamin D and TSH as Risk Factors or Prognostic Markers in Thyroid Carcinoma.Prediction Table and Nomogram as Tools for Diagnosis of Papillary Thyroid Carcinoma: Combined Analysis of Ultrasonography, Fine-Needle Aspiration Biopsy, and BRAF V600E Mutation.BRAF Mutations in an Italian Regional Population: Implications for the Therapy of Thyroid Cancer.Peptide nucleic acid clamp polymerase chain reaction reveals a deletion mutation of the BRAF gene in papillary thyroid carcinoma: A case report.Molecular pathology of thyroid cancer: diagnostic and clinical implications.Surgical implications of B-RafV600E mutation in fine-needle aspiration of thyroid nodules.Diagnostic markers and prognostic factors in thyroid cancer.Analysis of BRAF(V600E) mutation and DNA methylation improves the diagnostics of thyroid fine needle aspiration biopsies.Role of BRAFV600E mutation analysis and second cytologic review of fine-needle aspiration for evaluating thyroid nodule.Use of molecular biomarkers in FNA specimens to personalize treatment for thyroid surgery.BRAF mutation in cytology samples as a diagnostic tool for papillary thyroid carcinoma.Diagnostic value of B-RAF(V600E) in difficult-to-diagnose thyroid nodules using fine-needle aspiration: systematic review and meta-analysis.Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma".Diagnostic value of BRAF(V600E) mutation analysis of thyroid nodules according to ultrasonographic features and the time of aspiration.Values of molecular markers in the differential diagnosis of thyroid abnormalities.BRAF V600E mutation in papillary thyroid carcinoma: significant association with node metastases and extra thyroidal invasion.Molecular Diagnosis Using Residual Liquid-Based Cytology Materials for Patients with Nondiagnostic or Indeterminate Thyroid Nodules.Association between the BRAF V600E mutation and ultrasound features of the thyroid in thyroid papillary carcinoma.Contribution of the BRAF oncogene in the pre-operative phase of thyroid carcinoma.Comparison of Three BRAF Mutation Tests in Formalin-Fixed Paraffin Embedded Clinical Samples.High prevalence of B-RAF mutation in papillary carcinoma of the thyroid in north-east Italy.BRAF and RAS mutations in follicular variants of papillary thyroid carcinoma.ERK phosphorylation is not increased in papillary thyroid carcinomas with BRAF(V600E) mutation compared to that of corresponding normal thyroid tissues.Preoperative BRAF mutation has different predictive values for lymph node metastasis according to tumor size.BRAF V600E mutation: Differential impact on central lymph node metastasis by tumor size in papillary thyroid carcinoma.
P2860
Q26823658-C3E3A404-07C0-4BBA-9F6E-80455C6664FDQ33422171-F4BE9671-0077-4953-B7E0-8BE8285D31B4Q33760910-33F3B254-8FDD-4675-B000-F17DB9D1C45DQ33782114-61F90C96-CCC1-4AAB-AECF-D6744B4888B5Q33844111-F13FB672-B0EF-4CF6-9903-EEEA53312C0EQ33888762-3F6A8731-56C2-4405-A7E3-04FCDE3F1601Q34362091-8867D74C-6AE0-4FF8-9764-3D613C95DF8BQ34461136-98E2D005-A382-44A1-A634-32373A3BD93CQ34625948-93E118CB-ACDE-45AE-A39D-0D975BA3D7A8Q34650871-BEC30306-9FBA-41A7-9859-D5982A006E1FQ34839781-4ACCFC63-0A1C-4293-B04C-7FBC2236BB68Q35022501-4CEADA7E-77FF-4960-8F30-BF89BA2B1733Q35098913-8DE20A72-685B-4BAF-9163-C3430ADC6E33Q35583821-465C5B3A-2454-4B9A-9574-A3C41BA214F0Q36139842-DF817656-57EF-44A3-9C8E-E4762D0251BAQ36162969-3A885BF1-F9E1-4BBA-8266-FCAAB18756EAQ36193874-9CD77EBA-3045-496A-87C6-310BAC577A7BQ36360429-0F05FC82-4FE8-4E22-8CFD-278C3647EAD9Q37313241-4113840F-39F4-4E47-89B1-AF6BE23BBDA0Q37337504-EC36BAEC-A057-44EB-9855-3566D5436FF8Q37431090-2DE1DC1A-8184-4704-BB02-39469BBEB473Q37620399-8648C15E-B05E-4BD8-BFE7-B769CE1FD845Q37621631-BB863788-D957-4307-BAEB-48364FFBAAF1Q37900570-7CE519BB-96E1-45B5-A165-5E9D172E484AQ38042871-6EAFD6C3-4DE0-4FF8-ADBD-3F7681613396Q38088737-97AD2577-4A00-4E3D-98FF-E86C24477CCFQ38156151-E49B52EB-EDCA-4F24-A2DC-564646D71E8AQ38225733-BF6532ED-88CE-4EEC-94CE-9897C82D2446Q38480699-30F64FFE-60B0-430B-80C5-5C276B373940Q39051174-3C92C782-F409-41B1-B1C4-6379641F168FQ39439117-4919E39E-36EB-4263-B0C6-89A43055BB3DQ40165606-9F9756C4-3643-4181-8D46-528BE8FD3F36Q41143812-B32994EE-E74A-4DE5-BA10-C076D726C902Q41826094-0B8F67AE-38BC-4626-A2FD-B1F944CDB916Q41921961-710AF4A6-95F6-4D1A-92D7-8E14F8C93989Q44038195-7516981B-DB24-4196-ADAF-16EE88E4F82AQ45340508-721D9105-2814-47FA-B35D-3A6941388233Q46343415-2032218B-203B-40FC-8E22-ED3AB1F67AE4Q47366551-740A2FE7-4BAD-46CA-A877-75E090782350Q47369064-AB0F171D-EEE0-4BA6-AE19-3473B09698CF
P2860
Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Detection of BRAFV600E mutatio ...... F600E mutation-prevalent area.
@en
Detection of BRAFV600E mutatio ...... F600E mutation-prevalent area.
@nl
type
label
Detection of BRAFV600E mutatio ...... F600E mutation-prevalent area.
@en
Detection of BRAFV600E mutatio ...... F600E mutation-prevalent area.
@nl
prefLabel
Detection of BRAFV600E mutatio ...... F600E mutation-prevalent area.
@en
Detection of BRAFV600E mutatio ...... F600E mutation-prevalent area.
@nl
P2093
P2860
P1476
Detection of BRAFV600E mutatio ...... F600E mutation-prevalent area.
@en
P2093
Bo Youn Cho
Do Joon Park
Eun Sook Lee
Eun Young Kim
Geon Kook Lee
Hyun Sook Lee
Ki-wook Chung
Sang Hyun Lee
Sun Kyung Yang
P2860
P304
P356
10.1111/J.1365-2265.2006.02646.X
P577
2006-11-01T00:00:00Z